A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Shifu Xiao, Raoli He, Benyan Luo et al.|Alzheimer s Research & Therapy|2021

Cited by 200